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Executive Summary 
In November 2012, Colorado and Washington state became the first two US states to legalize the 
personal possession and retail sale of cannabis. The two states developed regulatory frameworks 
with many common features (e.g., minimum purchase age of 21, ban on public use), and some key 
differences. For example, Washington bans personal production, while Colorado permits up to five 
plants per household. The two states began with different contexts: Colorado had a well-established, 
regulated medical distribution system to build on, and Washington had no existing regulated supply. 
Retail sales began on January 1, 2014, in Colorado and on July 8, 2014, in Washington. 
To learn from evidence and experience about the legalization of cannabis for non-therapeutic use 
and its health, social, economic and public safety impacts, the Canadian Centre on Substance Abuse 
(CCSA) led delegations to Colorado (February 2015) and Washington state (August 2015). The 
delegations consisted of partners from public health, treatment and enforcement sectors. The goal 
was to inform the ongoing dialogue about policy options for the regulation of cannabis in Canada and 
internationally by observing the effects of the various models and approaches in the two states. The 
aim was not to take a position on the question of legalization, but to collect the best available 
information to support evidence-informed policy advice. To this end, the delegation met with 
stakeholders from a range of perspectives, including public health, regulation, government, 
enforcement, prevention and the cannabis industry.  
The overarching lesson that emerged during discussions with stakeholders was that any jurisdiction 
considering policy change should identify a clear purpose to drive the overall approach. In other 
words, begin by defining the problem to be solved and the goals to be achieved. 
Colorado and Washington had to develop a comprehensive regulatory framework taking a substance 
from criminal prohibition to retail sales. Any new regulatory system for cannabis needs to address 
considerations across health, public health, enforcement, criminal justice, social and economic 
sectors. It must account for the administration, monitoring and enforcement of all processes, 
including production, processing, sales, advertising and taxation. The framework also has to 
coordinate federal, state, district and municipal orders of government, and their respective roles in 
such areas as enforcement, taxation and health care. The CCSA delegation learned the following key 
lessons about developing a regulatory framework from stakeholders: 
 Reconcile medical and retail markets to promote consistency in such areas as purchase 
quantities and administration, and to reduce the scope of the grey market, which is the 
market for products produced or distributed in ways that are unauthorized or unregulated, 
but not strictly illegal;  
 Be prepared to respond to the unexpected, such as the overconsumption of edibles in 
Colorado and an unmanageable volume of licensing applications within a limited timeframe 
in Washington state;  
 Control product formats and concentrations to ensure there are no unanticipated 
consequences from unregulated formats and concentrations; 
 Prevent commercialization through taxation, rigorous state regulation and monitoring, and 
controls on advertising and promotion; and 
 Prevent use by youth by controlling access and investing in effective health promotion, 
prevention, awareness and education for both youth and parents. 
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The need to invest in effective implementation was a common message of stakeholders in both 
Colorado and Washington. They highlighted the value of allocating a portion of funds generated 
through retail sales to education, prevention, treatment and research. They also emphasized the 
need to ensure proactive investment to build capacity before the new regulations are implemented 
and retail sales begin. These investments fall into several common themes: 
 Take the time required to develop an effective framework for implementation and to prepare 
for a successful launch; 
(Colorado stakeholders recommended taking longer than the one-year period provided in 
that state. There is also a need to give retailers time to develop capacity to meet consumer 
demand. Washington stakeholders encountered price escalation as retailers struggled to 
obtain or produce product within two months of receiving licenses.)  
 Develop the capacity to administer the regulatory framework, recognizing that a significant 
investment in staff and administration is required to process licenses, conduct 
comprehensive inspections and address violations; 
 Provide strong central leadership and promote collaboration to bring diverse partners to the 
table from the beginning and to promote open, consistent communication and collaborative 
problem-solving;  
 Invest proactively in a public health approach that builds capacity in prevention, education 
and treatment before implementation to minimize negative health and social impacts 
associated with cannabis use;  
 Develop a clear, comprehensive communication strategy to convey details of the regulations 
prior to implementation, so that the public and other stakeholders understand what is 
permitted, as well as the risks and harms associated with use, so that individuals can make 
informed choices;  
 Ensure consistent enforcement of regulations by investing in training and tools for those 
responsible for enforcement, particularly to prevent and address impaired driving and 
diversion to youth, and to control the black market;  
 Invest in research to establish the evidence base underlying the regulations, and to address 
gaps in knowledge, such as new and emerging trends and patterns of use; and  
 Conduct rigorous, ongoing data collection, including gathering baseline data, to monitor the 
impact of the regulatory framework and inform gradual change to best meet policy objectives 
and reduce negative impacts. 
In summary, the consistent message CCSA heard was that any jurisdiction considering regulatory 
changes to cannabis policy should take the time to set up the infrastructure and allocate the 
resources needed to get it right, assess impacts along the way and make incremental changes, as 
needed. 
CCSA would like to thank the Colorado and Washington stakeholders and Canadian delegation 
members for their generous contributions of time, expertise, information and advice.  
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Objective 
The Canadian Centre on Substance Abuse (CCSA) is Canada’s only national agency dedicated to 
reducing the harms of alcohol and other drugs on society, informing policy and practice, and 
improving services, supports and care for those suffering from substance use disorders.  
To this end, and in light of ongoing dialogue about the impacts and policy options for the regulation 
of cannabis1 in Canada and internationally, CCSA coordinated visits with partners to Colorado and 
Washington state in February and August, 2015, about a year after retail sales of cannabis were 
implemented in each state. These visits brought senior CCSA leadership and subject-matter experts, 
and partners from public health, treatment and enforcement to meet with diverse stakeholders to 
learn from evidence and experience about the health, social, economic and public safety impact of 
cannabis legalization.2 The purpose of these visits was not to arrive at a position on the question of 
legalization, but to ensure that CCSA has the best available information with which to provide 
evidence-informed policy advice on the issue of cannabis regulation in a timely way.  
CCSA has produced this report to summarize the key themes and lessons learned during the two 
visits. The report is based on the notes recorded and input provided by delegation members.  
Background 
Legislative approaches to regulating cannabis fall along a continuum, with criminal prohibition, the 
currently dominant model in Canada and internationally, at one end and unrestricted access and 
free market production at the other (see Appendix D). The question of how cannabis should be 
regulated has recently been raised at both national and international levels. It was an issue in 
Canada’s recent federal election, and has been raised by the United States Office of the Attorney 
General and at the 58th session of the United Nations Commission on Narcotic Drugs. Despite a 
great deal of dialogue, a lack of clarity remains about the differences between decriminalization, 
legalization and commercialization of cannabis, and the various regulatory options and models 
within each category (Canadian Centre on Substance Abuse, 2014). 
Cannabis is illegal for retail sale at the federal level in the United States, as it is in Canada. However, 
23 states and the District of Columbia have passed legislation allowing medical use, and four states 
(Colorado, Washington state, Oregon and Alaska) and the District of Columbia have passed 
legislation allowing retail sales.  
The discrepancy between the status of cannabis with the federal and state orders of government 
creates significant challenges. Because cannabis remains a scheduled substance at the federal 
level, the state is forced to take responsibility for regulations, inspections and enforcement normally 
handled by federal departments and agencies such as the Food and Drug Administration or the 
Department of Agriculture. This situation also prevents normal banking operations, resulting in a 
primarily cash-based industry with corresponding safety and administrative issues. Although banking 
capacity has developed to an extent in Washington through smaller credit unions, transactions are 
limited to the production level and retail sales remain cash-based. The discrepancy also creates 
                                                 
1 The terms “cannabis” and “marijuana” both refer to the dried flowers, fruiting tops and leaves of Cannabis sativa. CCSA uses the term 
cannabis; this report uses the term marijuana when it is part of a formal title such as the Office of Marijuana Coordination. 
2 Appendix A provides a list of the CCSA delegation members, Appendix B a list of Colorado stakeholders, and Appendix C a list of 
Washington State stakeholders. Stakeholders were identified through a combination of referrals from existing networks, suggestions from 
contacts as they were made in each state, and targeted searches for individuals in key roles representing the broad range of perspectives 
sought (e.g., public health, enforcement, administration, regulation, government, industry, prevention, treatment).  
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jurisdictional challenges for enforcement. For example, in Washington state the federal Coast Guard 
is responsible for enforcing federal laws — under which cannabis is illegal — on navigable waterways 
and for public safety on ferries and other vessels travelling between the mainland and islands; 
however, federal ferries are the only means of transportation available to some islands within 
Washington state. 
The first two states to legalize the personal use and possession of cannabis for non-therapeutic purposes 
were Colorado and Washington state, which passed Amendment 64 and Initiative I-502 respectively in 
November 2012. Table 1 compares key components of the new regulations in the two states.  
Colorado began retail sales on January 1, 2014, by permitting existing licensed medical distributors 
to transfer to non-therapeutic sales. This approach leveraged Colorado’s existing framework for 
medical cannabis, which included state licensing. Retail licensing expanded to new retailers in 
October 2014. Licenses must be approved by both the Marijuana Enforcement Division of the 
Department of Revenue and relevant local licensing authorities, the latter of which have the 
authority to prohibit retail sales altogether. Of Colorado’s 321 local jurisdictions, only 72 had allowed 
retail sales as of December 2014 (Brohl, Kammerzell, & Koski, 2015).  
Washington state began retail sales under the supervision of the Washington Liquor Control Board 
on July 8, 2014. Initial licensees were drawn from a pool of suitable applicants in May 2014. This 
two-month time period for the licensees to produce or obtain stock and establish points of sale 
resulted in limited initial retail capacity with a gradual scale-up over subsequent months. As in 
Colorado, municipal authorities can impose restrictions from hours of operation to caps on the 
number of retail outlets up to complete bans on sales. Although Washington state did not have a 
regulated medical market, unregulated retail sales were taking place, with over one hundred 
distribution centres in Seattle alone.  
Table 1: Summary of Colorado and Washington Regulatory Frameworks 
 Colorado Washington state 
Age restrictions 21 or older 21 or older 
Personal possession 1 oz or its equivalent 
A combined maximum of: 
1 oz dried product 
16 oz infused solid product 
72 oz infused liquid product 
7 g concentrates 
Personal production 
Up to 6 plants (maximum 3 mature) that 
must be in an enclosed, locked space 
Not permitted 
Licensing body Colorado Department of Revenue Washington State Liquor and Cannabis Board 
Taxation 
15% excise; 10% sales + municipal taxes 
(approx. 30% of total price) 
Prior to July 1, 2015: 25% excise tax at each 
of production, processing and retail sale 
stages + state and local sales taxes (approx. 
50% of total price) 
As of July 1, 2015: 37% excise tax + state 
and local sales tax  
Forms of sale Dried marijuana, extracts and infusions Dried marijuana and infusions 
Residency 
restrictions 
Purchase limit of ¼ oz for non-residents 
Retailers and producers must have lived in 
the state for 2-years  
Retailers and producers must have lived in 
the state for 3-months 
Driving restrictions 5 nanograms/ml THC in whole blood 5 nanograms/ml THC in whole blood 
Public use Not permitted Not permitted 
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The Colorado and Washington state approaches to medical marijuana also form an important part of 
the regulatory context. Although both states permit the use of marijuana for therapeutic purposes, 
they differ greatly in terms of the existing degree of state regulation.  
Colorado’s medical market underwent significant expansion in 2009 after a successful court 
challenge created an opportunity to set up medical cannabis distribution centres. The Colorado 
Medical Marijuana Code was subsequently passed in 2010, establishing statewide regulations 
governing the use and sale of cannabis for medical purposes (Office of the State Auditor, 2013). As 
of January 1, 2014, 493 medical distribution centres had been opened (Brohl et al., 2015). The 
number of medical cards issued also subsequently increased from 5,051 in January 2009 to 
111,031 in January 2014 (Light, Orens, Lewandowski, & Pickton, 2014). Colorado’s medical market 
therefore served as a foundation for the retail model by providing a network of established, licensed 
producers and retailers. 
Conversely, although Washington state has permitted the use, possession, sale and cultivation of 
cannabis for authorized patients since 1998, the state had not established comprehensive 
regulations governing distribution or patient registration. Regulations were limited to authorized 
medical conditions and limits were set for the quantity of plants or product allowed in an individual’s 
possession. Washington is currently in the process of implementing regulations that will bring 
medical distribution into alignment with the retail system, which will be addressed later in this report. 
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Lessons Learned 
The CCSA delegation met with a number of individuals and organizations representing a broad spectrum 
of perspectives, including regulation, enforcement, public health, cannabis industry, research, data 
collection and treatment, and advocates on both sides of the legalization debate (see appendices B and 
C). Many stakeholders identified the importance of beginning by clearly identifying the problem to be 
solved and focusing regulation, messaging, data collection and implementation accordingly.  
Several consistent lessons learned through the legalization experience in Colorado and Washington 
state emerged over the course of the consultations, and there were key messages that tied these 
lessons together. Stakeholders in both states emphasized the importance of taking the time and 
making the proactive investments needed for a strong and comprehensive regulatory framework. 
That framework should include the infrastructure needed to address public health and safety 
concerns such as cannabis use among youth and cannabis-impaired driving. Also before legalization, 
a jurisdiction should gather comprehensive baseline data and after legalization continue ongoing 
research and data collection on the health and social impacts of cannabis use.  
Identify a Clear Purpose to Drive the Overall Approach 
The CCSA delegation heard the old catchphrase “the devil is in the details” many times during its 
consultations. Identifying clear policy goals is an important way to ensure that regulatory details 
provide a consistent strategic approach and provide measures against which to monitor and 
evaluate progress and impact. The legalization of cannabis is often promoted as a way to reduce the 
black market and the role of organized crime, reduce the impact of criminal charges on those 
apprehended for possession, improve product safety and generate tax revenue. Depending on how 
these goals are prioritized, details such as taxation structure can vary considerably. For example, if 
the goal is to price out the black market, the taxation structure will be set up differently than if the 
goal is to generate state revenue.  
Develop a Comprehensive Regulatory Framework 
The challenge of developing an entirely new framework for regulating a previously illegal substance 
cannot be underestimated. As illustrated in Table 1, there is a great deal of consistency in the 
Colorado and Washington approaches, as well as some key distinctions. This section outlines the key 
themes that emerged about establishing the regulatory framework.  
Reconcile medical and retail markets 
Stakeholders in both Colorado and Washington state remarked on the challenges associated with 
the co-existence of retail and medical markets. In both states, the pre-existing medical regulations 
create a system of dual standards (e.g., different minimum ages, purchase quantities, growth 
restrictions, and taxation levels) and contribute to the grey market, which is the market for products 
produced or distributed in ways that are unauthorized or unregulated, but not strictly illegal. The grey 
market associated with personal production is especially difficult to regulate and enforce. For 
example, Colorado’s Amendment 64 allows medically authorized individuals to produce up to six 
plants for personal use, and designated caregivers can grow up to six plants for up to five people, as 
well as for themselves. Stakeholders identified that plants grown within this market constitute about 
one-third of the total supply, and pose a high risk for diversion both to youth and to out-of-state 
destinations.  
Cannabis Regulation: Lessons Learned In Colorado and Washington State 
Canadian Centre on Substance Abuse • Centre canadien de lutte contre les toxicomanies  Page 7 
Stakeholders emphasized the importance of distinguishing between cannabis’ function as a medical 
substance and as a recreational substance. When that function is medical, stakeholders agreed that 
cannabis should be treated as such in terms of dosage, guidelines, production, distribution and 
product configuration (i.e., it should not be supplied in candy form). Several stakeholders noted that 
there was a need for healthcare professionals to have a stronger voice in the regulatory system. They 
highlighted the lack of conclusive research in some areas and the dual medical–recreational 
function of cannabis as barriers to engaging the health field more strongly.  
In Colorado, although the medical market is currently larger than the retail market, trend data 
suggests the gap is closing (Brohl et al., 2015). There are incentives for both options. Using the retail 
market eliminates the burden of renewing a medical card every year. However, when purchasing with 
a medical card, the price is lower because of lower taxes. Further, youth between the ages of 18 and 
21 can access cannabis for medical use, and youth below the age of 18 can access cannabis for 
medical use with parental approval. Examining the extent to which individuals approved to access 
cannabis for medical use choose to change to the retail market will contribute to understanding 
possible interactions between the two markets and overall impacts on rates of use.  
Washington state is in the process of introducing regulations that will bring the medical market into 
alignment with the retail market. Because medical distribution centres are currently unlicensed, 
there is no accurate data on their number; however, estimates indicate 100 to 300 in the Seattle 
area alone and 500 to 800 state-wide. Senate Bill 5052, passed in September 2015, requires that 
all retail outlets obtain licenses through the Washington Liquor and Cannabis Board. A special 
endorsement will be required to allow the provision of authorized medical users with tax exemptions, 
higher purchase quantities and a lower purchase age of 18 years.3 All dispensaries are required to 
be licensed by July 2016. Washington state is not placing a cap on the number of new permits 
issued, and is prioritizing dispensaries established prior to January 1, 2013 in the licensing process. 
The Washington State Economic and Revenue Forecast Council estimates that bringing the medical 
market into state regulation will close to double sales revenue and market share. 
Be prepared to respond to the unexpected 
Stakeholders agreed that despite best efforts in proactively identifying challenges, there are always 
surprises. Regulatory frameworks therefore need to be flexible and agile enough to adapt to these 
surprises and mitigate potential harms. Stakeholders also agreed that moving gradually and 
decreasing the restrictiveness of regulations is easier than increasing them, so they recommended 
beginning with a more restrictive framework and easing restrictions as evidence indicates. 
Colorado’s experience with edible cannabis products illustrates the importance of this theme. Sales 
of cannabis edibles is the one area in which retail cannabis sales overtook medical, with 2.85 million 
and 1.96 million units sold, respectively (Brohl et al., 2015). Initial regulations set a maximum 
dosage for edible products, but did not specify how that dosage was to be distributed relative to 
serving size. Many producers packaged edibles with several doses in what most consumers would 
consider one serving of a product; for example, a single brownie could contain up to ten doses. 
Cannabis ingested in edible form can also take over an hour to produce psychoactive effects, 
introducing a higher risk for overconsumption among naïve users.  
Several high-profile overdoses from consuming edible forms of cannabis generated media attention, 
and a task force was struck in April 2014 to revisit the regulations. New regulations were introduced 
in February 2015 requiring edible products to be separated into doses of 10 mg of tetrahydrocannabinol 
                                                 
3 Detailed requirements and regulations for this endorsement remain in development at the time this report is being written. 
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(THC) or less. The new regulations created significant losses for producers who had to change 
manufacturing processes and dispose of products that did not meet the new regulations.  
Washington stakeholders noted the unexpected volume of applications received for the initial lottery-
based licenses. In hindsight, a rolling rather than fixed application period would have distributed the 
volume over a longer period of time, allowing more time to review and work with applicants to ensure 
that those provided with license opportunities could meet all criteria. Washington also made a 
significant change to its taxation approach. The initial tax structure imposed a 25% tax at each stage 
of production, processing and sale. This structure prevented retailers from claiming the taxes as a 
business expenditure when filing their own corporate taxes. The state has therefore shifted to a 37% 
tax imposed at point of sale, and eligible for retailers to claim against revenue. This shift is not 
anticipated to reduce overall revenues generated for the state, or to increase costs to consumers.  
Control product formats and concentrations 
A theme that emerged in both Colorado and Washington was concern about the emergence of 
products containing high levels of THC, including both plants and extracts such as oils. Stakeholders 
from the public health and research communities in particular pointed out that there are gaps in 
knowledge about the long-term health impacts of consuming products with higher THC, and about 
trends in their use as surveys typically ask about smoking rather than other methods of use. There are 
also gaps in public education about the different effects and risks associated with the use of different 
formats; for example, the longer time of onset associated with edible versus smoked products.  
The challenge faced in Colorado with packaging and dosage of edibles, as described previously, 
illustrates the unanticipated consequences for both consumers and producers of unregulated 
product formats. Several stakeholders also expressed continuing concern that many edible products 
are virtually identical to other candy or baked goods, and could be mistakenly ingested, particularly 
by youth, and supported more rigorous regulation of product formats. Stakeholders discussed 
several possible mechanisms for control, including limitations on THC concentration, imposing 
differential taxation levels according to THC concentration, and restricting product formats such as 
candies that might be more appealing to youth.  
Prevent commercialization 
Stakeholders agreed that avoiding commercialization, or the active promoting and marketing of 
cannabis, is the most important factor in preventing significant public health impacts such as those 
seen with the commercialization of alcohol and tobacco. Stakeholders suggested areas for particular 
attention, including taxation, a tightly controlled state distribution model, and strict regulations on 
advertising and promotion. Many stakeholders also recognized that the profit motives involved in a 
promising market are likely to attract corporate interests including or similar in nature to “big 
tobacco,” with a corresponding concern that profit motives will overtake any concerns for individual 
or public health. These motives are supported by initial sales figures, totalling approximately $313M 
US in Colorado in 2014 and $260M US in Washington state from July 2014 to June 2015. 
As a stakeholder in Washington remarked, commercialization is embedded in the economic culture 
of the United States. Colorado and Washington state are approaching this issue differently. Colorado 
is now moving away from a requirement for vertical integration from production to sale, and 
Washington is preventing vertical integration by allowing only retailers to hold retail licences, 
whereas producer and processor licences can be held concurrently. Monitoring the success of the 
various approaches being taken to limit the formation of large cannabis businesses in Colorado and 
Washington, as well as the states that have more recently introduced regulation, will provide 
valuable lessons learned. 
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Another lesson learned from research on the alcohol market is that consumption is directly related to 
availability. Some stakeholders expressed concern with the density of retail sales outlets, particularly 
in Denver, and with the location of some outlets relatively close to schools. Washington state has 
taken measures to prevent this problem from developing by applying caps on the number of licenses 
and developing regulations on location, including density and proximity to certain venues frequented 
by youth (e.g., schools). Some stakeholders remarked that these regulations drive locations to 
industrial and other areas that are inconvenient for customers to access.  
Prevent use by youth 
All stakeholders agreed that cannabis is not a benign substance and young people are at a higher 
level of risk for experiencing negative impacts. For example, heavy or regular cannabis use in early 
adolescence can have lasting effects on the developing brain (Porath-Waller, Notarandrea, & 
Vaccarino, 2015). There are indications that youth are more likely to use products in concentrated 
form with higher levels of THC and to use cannabis in combination with other substances. Several 
stakeholders expressed concern about advertisements, packaging and formats that are attractive to 
youth. As previously noted, stakeholders in Colorado expressed particular concern about products 
allowed on the markets that are formatted to mimic popular brand-name snacks and candies. 
Washington state regulations have not permitted edibles in “candy” form for retail sale, although 
they do exist in the unregulated medical market.  
Stakeholders in both Washington and Colorado also agreed that reducing the negative impacts on 
youth should be a priority for any policy model. Acting on this priority includes closely monitoring 
youth rates of use and access to diverted product, and the health and social impacts on youth. The 
state must invest proactively in health promotion and prevention, and awareness and education for 
both youth and parents. Stakeholders pointed out the challenges in determining the impact on youth 
rates of use. For example, school surveys have not traditionally separated cannabis from other 
substances or asked about mode of use (e.g., smoking, edibles or vaping), and the methodologies of 
state and national youth surveys vary. These methodological variations result in different 
interpretations of impact depending on which data source and analytical approach are being used 
(Retail Marijuana Public Health Advisory Committee, 2015). 
Invest in Effective Implementation 
Developing a regulatory framework is only one piece of the puzzle. Implementing the framework and 
ensuring that there is the capacity and infrastructure needed to support it is also vital. Stakeholders 
particularly emphasized the need for proactive investment to build capacity before implementation, 
rather than waiting for revenues generated through taxation. This section outlines key themes that 
emerged about implementation.  
Take the time required to develop an effective framework for implementation 
Both Colorado and Washington experienced challenges with timing. Colorado had about one year to 
develop and implement a regulatory structure for retail production and distribution of cannabis. 
Stakeholders agreed that this was an aggressive timeline. A condensed timeline limits opportunities 
to engage stakeholders, collect data, conduct research, and ensure that regulatory agencies and 
other partners (e.g., enforcement and health professionals) can determine resource requirements 
and train staff. Stakeholders also pointed out that Amendment 64 outlined a framework within which 
they had to work, so they did not have the opportunity to craft regulations specifically to reflect 
available evidence on public health and safety impacts. 
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Washington waited an additional six months to implement, and many stakeholders felt that this 
provided a better opportunity to develop a comprehensive regulatory framework. The difficulty 
encountered in Washington was primarily with launching the retail market. Initial retailers had a 
period of only two months between license approval and the first legal sales date of July 8, 2015. 
Most retailers required additional time to produce or obtain product, establish locations and engage 
staff; resulting in limited product availability, price inflation and consumer frustration. 
Develop the capacity to administer the regulatory framework 
Stakeholders noted that regulatory bodies need to develop physical and human resources to 
administer the new regulations. Administration includes processing licence applications and renewals, 
conducting inspections, fielding complaints and addressing violations. In Colorado, for example, the 
Department of Revenue has taken on 55 new full-time employees to handle administrative and 
regulatory requirements. The City of Denver has added 37.5 full-time employees across sectors 
including administration, health, the coroner’s office, public safety and emergency response.  
Over the course of 2014, the Colorado Department of Revenue processed licenses for 322 retail 
stores, 397 retail cultivations, 98 product manufacturers and 16 testing facilities, as well as 77 
denials, 30 suspensions, ongoing field inspections and other activities (Brohl et al., 2015). There are 
also costs associated with legal challenges by those denied licenses.  
In Washington, the Washington State Liquor and Cannabis Board reported taking on 22 new full-time 
employees at a cost of $5M. From July 2014 to June 2015, the Board issued 131 producer, 275 
processor and 161 retail licences. Stakeholders remarked that resources for inspections were 
limited and complaint-driven rather than proactive.  
Provide leadership and promote collaboration 
Stakeholders in both Colorado and Washington highlighted the value of central leadership to 
facilitate coordination and collaboration across the broad range of stakeholders involved in and 
affected by implementing cannabis regulations. In Colorado, the Governor’s office created the Office 
of Marijuana Coordination with a leadership mandate. Stakeholders reported being involved to some 
degree on various working groups to develop, implement and amend regulations. They confirmed 
that this cross-sectoral approach was valuable for bringing all perspectives to the table from the 
beginning, generating consensus solutions to challenges, promoting consistency of information and 
avoiding conflict. From the administrative perspective, this approach smoothed implementation by 
ensuring ongoing communication across departmental divisions and enabling quick identification 
and attention to unintended impacts.  
Stakeholders in Washington state pointed out that the absence of central leadership was a gap in 
the development of a regulatory framework in their state. Addressing that gap would have 
contributed to smoother implementation and improved understanding across sectors.  
Invest proactively in a public health approach 
One dominant rationale for cannabis legalization is the increased opportunity for a public health 
approach that includes prevention, education and treatment, in contrast with an enforcement 
approach focused on legal sanctions. A portion of sales revenue in both Colorado and Washington 
has been designated to support prevention and education initiatives. However, revenue-based 
funding by nature means a delay between the initiation of sales and the availability of funding, which 
results in limited resources prior to and early in the implementation stage — the period during which 
these initiatives are most needed. In addition, taxation revenue in Washington that was initially 
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earmarked for cannabis-related prevention, education, treatment, regulation and research has been 
reallocated to the general revenue stream, which reduces the funding available for public health. 
A public health approach is comprehensive and stakeholders highlighted the need to build capacity 
across all system components that would be impacted by cannabis legalization. Stakeholders in 
Colorado in particular remarked on the importance of ensuring that resources are in place to 
address potential impacts on the health sector from emergency hospital admissions, poison control 
incidents and demand for treatment. 
Stakeholders cautioned that lobbying by the cannabis industry could influence political decision 
making in favour of retail profit over public health. These concerns were more prominent in Colorado, 
where an established and coordinated industry presence has been part of the collaborative 
development process. 
Develop a clear, comprehensive communications strategy 
Stakeholders in both Colorado and Washington commented on the high level of public misunderstanding 
about the details of the legislation, both leading up to the initial vote and following the development 
of the regulatory framework. Clarity among the public about the legislation is important to reducing 
the health, social and public safety impacts. For example, people must know about possession and 
purchase limits, and restrictions on use in public and below the age of 21. Stakeholders emphasized 
the importance of communicating restrictions on cannabis-impaired driving and informing the public 
that police do have a scientifically validated method for testing for impairment.  
Clear messaging about the risks and harms of cannabis use — integral to the public health approach 
— is important for reducing negative health impacts. Evidence indicates that the perception of harms 
associated with cannabis use is inversely related to rates of use among youth (Johnston, O’Malley, 
Miech, Bachman, & Schulenberg, 2015). Stakeholders pointed out that, to be perceived as credible, 
factual information about the health impacts of cannabis use must be conveyed in a way that is 
balanced and unsensational. They noted the value of drawing on lessons learned from campaigns 
against alcohol-impaired driving. Further, stakeholders highlighted the need for targeted communications 
to address specific risky behaviours, such as cannabis-impaired driving and use in combination with 
other substances including alcohol. Communications must also be developed to educate the public on 
the varied effects of different product formats and concentrations (e.g., delayed onset with edibles).  
Ensure consistent enforcement of regulations 
Stakeholders agreed there remains a strong role for enforcement under legalization, especially in 
areas such as driving while impaired, use in public, distribution to youth, and black market 
production and diversion. Enforcement stakeholders in Colorado, for example, remarked that they 
had observed an increase in the black market because of the increased ease of production and the 
profits associated with exporting to neighbouring states. Investing in education, training, analysis 
and investigative capacity is important to ensure consistent and effective enforcement of the 
regulations. Colorado stakeholders noted that adequate resources had not been invested to ensure 
access to the training required for effective and consistent enforcement. Several Washington 
stakeholders felt that frontline officers did not view enforcement of the regulations as a priority, 
which led to the normalizing of transgressions such as use in public. Colorado stakeholders pointed 
out the lack of labs for sample analysis as a significant obstacle, whereas Washington stakeholders 
emphasized that the availability of testing labs and the scaling up of impaired driving detection 
capacity before legalization had been especially beneficial.  
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Invest in research to establish the evidence base 
Stakeholders in both Colorado and Washington pointed out that there are gaps in knowledge about 
patterns and impacts of cannabis use. Colorado stakeholders in particular identified that more time 
and resources would have enabled regulators to work with the health and research communities to 
gather existing scientific knowledge on the impacts of use, identify gaps and inform the regulatory 
framework. The legal status of cannabis has restricted access to it for research purposes, which has 
limited the ability to collect evidence on the impacts of use. Stakeholders pointed out that research 
institutions in states that have legalized cannabis risk losing federal funding by using local supplies 
instead of federally approved product. 
It was also remarked that the uniformity of cannabis supplied by the federal government for research 
further limits the information available on products with higher concentrations of THC. Emerging 
trends in use, such as consumption of these products, have created important gaps in knowledge 
about acute and long-term health impacts. Cannabis concentrates, in the form of oils and resins, 
provide levels of THC in excess of those possible in the plant form. The acute and long-term impacts 
of these products is currently unknown and of particular concern for high-risk groups. Evidence on 
these impacts would be valuable to inform product regulations or guidelines and public awareness. 
Conduct rigorous, ongoing data collection 
As the first states to enact a legalized regulatory framework for cannabis, Colorado and Washington 
are in a unique position to contribute to the evidence base on the impacts of regulatory change. 
There are many different perspectives, for example, on potential tax revenue, impact on organized 
crime and health, and impact on rates of use among both adults and youth (e.g., Light et al, 2014; 
Caulkins, Andrzejewski, & Dahlkemper, 2013).  
Monitoring impacts is also necessary to determine if policy objectives are being met, and to identify 
unanticipated impacts in a timely manner. However, many stakeholders in both Colorado and 
Washington expressed frustration that lack of baseline data meant they could not answer many 
fundamental questions about the impact of legalization. For example, many data systems did not 
report cannabis separately from other illicit substances, (e.g., school expulsion and suspension 
data), did not ask about the use of different product formats (e.g., smoked versus edibles), or did not 
systematically screen for the presence of cannabis (e.g., emergency rooms and coroners’ reports). 
Different data collection and analytical approaches, and reporting timelines contribute to inconsistent 
results. Stakeholders agreed that quality data would enable a more evidence-driven approach.  
Data collection is subject to availability bias, with sales revenue and taxation data being easier to track 
and report than complex multi-sectoral direct and indirect costs (e.g., poison control calls, emergency 
visits, hospital stays, treatment numbers, impaired driving fatalities, enforcement training, tourism and 
employment). Several stakeholders noted the importance of clarifying the research question (e.g., what 
is the problem the new regulation is trying to solve?) and then collecting and analyzing data 
strategically to make more efficient use of resources and produce more relevant results.  
In Colorado, data on poison control, hospitalizations and emergency department visits have, for 
example, indicated an increase in cannabis-related incidents between January and June 2014 
(Retail Marijuana Public Health Advisory Committee, 2015). However, further analysis is needed to 
determine if this increase is a result of legalization or other factors such as increased awareness and 
willingness to report a previously illegal behaviour. Similarly, increases in cannabis-impaired driving 
incidents in Washington are being attributed by some stakeholders to the new regulatory framework 
(e.g., Couper and Peterson, 2014); however, others point out that confounding factors such as a 
recent Supreme Court ruling and increased detection capacity are likely driving this increase. 
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Additional data collected over time will be needed to demonstrate whether any impact is sustained. 
Although preliminary evidence does not indicate changes in prevalence of use, stakeholders in 
Washington did point out that there are indications that perceived risk of cannabis use is decreasing. 
Evidence supports an inverse relationship between perceived risk and rates of use, meaning that 
when perceived risk decreases, rates of use increase.  
Colorado is addressing gaps in information by adding questions about cannabis to state-level public 
health surveys for adults, youth, pregnant women and new mothers (Retail Marijuana Public Health 
Advisory Committee, 2015). Results from these surveys is anticipated in fall 2015, but information 
on the impact of Amendment 64 will be limited by the lack of comparable baseline data. There is 
also work underway on questions to collect data on the costs associated with cannabis-related 
hospital visits and rates of driving while impaired by cannabis. 
The passage of I-502 in Washington state included the direction of resources to the Washington State 
Institute for Public Policy to conduct a comprehensive cost-benefit evaluation of its implementation. 
The evaluation was to cover impacts on public health, public safety, substance use, the criminal justice 
system, economy and administration (Washington State Institute for Public Policy, 2015). The 
evaluation issued its first report in September 2015, outlining the evaluation plan and baseline 
measures. The first report to provide initial outcome analyses is scheduled for September 2017.  
Stakeholders in Washington said they are working with colleagues in other states to promote 
consistent approaches to measuring impact. This consistency will be extremely useful in providing 
comparable data, particularly in areas such as criminal justice and the black market, where reliable, 
quantifiable indicators are less available.  
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Conclusions and Next Steps 
The overarching message that the CCSA delegation heard from Colorado and Washington 
stakeholders was that if a jurisdiction is considering regulatory changes to cannabis policy, it should 
identify the central goal or problem to be solved, and use this goal to inform regulations, data 
collection and public awareness initiatives. A comprehensive regulatory framework should, for 
example, take into account legislation and policy, public awareness and prevention, health 
interventions and treatment, detection, deterrence and enforcement, adjudication and sanctions, 
and evaluation.4 They also identified the importance of taking the time and investing the resources 
needed to get it right, assessing impacts along the way, and making incremental changes to respond 
to emerging lessons learned. Stakeholders also agreed that decreasing regulations is easier than 
increasing them, and so advised beginning with a more restrictive framework and easing restrictions 
when appropriate.  
Much of the data needed to fully evaluate the impact of cannabis legalization is not yet available, and 
CCSA will continue to monitor it closely as it emerges. These efforts will be greatly helped by the 
contacts and relationships established through CCSA’s meetings with Colorado and Washington state 
stakeholders. CCSA will also monitor the emerging policy frameworks in Oregon, Alaska and 
Washington, DC, following successful legalization campaigns in those jurisdictions in November 2014. 
CCSA will use the information gathered from the fact-finding trips to Colorado and Washington state 
to ensure its contribution to the ongoing dialogue on cannabis policy is informed by the best 
available evidence. CCSA emphasizes that any changes to cannabis policy should be made based on 
the principles of applying available evidence, reducing negative health, social and criminal justice 
impacts, and promoting public health and the equitable application of the law.  
CCSA recommends that the dialogue on cannabis policy in Canada begins by defining the problems 
or harms to be addressed. CCSA also recommends taking advantage of the opportunity to inform the 
Canadian dialogue with the impacts and lessons learned through the implementation of various 
policy options internationally. 
                                                 
4 Based on a framework developed by CCSA to guide the development of a comprehensive regulatory response to the problem of drugs 
and driving.  
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Appendix A: CCSA Delegations 
Colorado 
CCSA Senior Leadership 
Rita Notarandrea, Chief Executive Officer 
Rho Martin, Deputy Chief Executive Officer  
CCSA Subject Matter Experts 
Health — Amy Porath-Waller, Director, Research and Policy 
Policy — Rebecca Jesseman, Senior Policy Advisor and Director, Information Systems and 
Performance Measurement 
External Delegates 
Gary Bass, Member, CCSA Board of Directors, and Superintendent (retired), Royal Canadian 
Mounted Police 
Ian Culbert, Executive Director, Canadian Public Health Association 
Washington State 
CCSA Senior Leadership 
Rita Notarandrea, Chief Executive Officer 
CCSA Subject Matter Experts 
Health — Amy Porath-Waller, Director, Research and Policy 
Policy — Rebecca Jesseman, Senior Policy Advisor and Director, Information Systems and 
Performance Measurement  
External Delegates 
Trevor Bhupsingh, Director General, Law Enforcement and Border Strategies Directorate, Public 
Safety Canada 
Inspector Michael Carlson, Royal Canadian Mounted Police  
Ian Culbert, Executive Director, Canadian Public Health Association 
Inspector Mike Serr, Vancouver Police Department 
Lori Spadorcia, Vice President of Communications and Partnerships, Centre for Addiction and Mental 
Health 
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Appendix B: Colorado Stakeholders 
Meeting Host Individual Role (Organization if different from meeting host) 
Colorado Department of 
Revenue 
Barbara Brohl Executive Director 
Ron Kammerzell Deputy Senior Director of Enforcement 
Lewis Koski Director, Marijuana Enforcement Division 
SMART Colorado 
Gina Carbone Founding member 
Henny Lasley Board member 
Jo McGuire Speaker 
Colorado Tobacco Education 
and Prevention Alliance  
Bob Doyle Executive Director 
Marijuana Industry Group Michael Elliott Executive Director 
Springs Rehabilitation Ken Finn Service Provider 
Office of the Governor 
Andrew Freedman Director of Marijuana Coordination 
J. Skyler McKinley Deputy Director of Marijuana Coordination 
Vicente Sederberg LLC 
Christian Sederberg Attorney at Law 
Andrew Livingston Policy Analyst 
Joshua Kappel Attorney at Law 
Colorado Enforcement 
(multiple organizations) 
Ashley Kilroy Denver Marijuana Coordinator 
Ben Cort CeDAR; SMART Colorado 
Bruce Mendelson Denver Drug Strategy 
Chelsey Clarke Rocky Mountain High Intensity Drug Trafficking Area 
Chris Halsor Understanding 420 
Jack Reed 
Statistical Analyst, Office of Research and Statistics, Colorado 
Department of Public Safety  
James Henning Denver Police Department 
Jim Burack Colorado Department of Revenue, Marijuana Enforcement Division 
Kevin Wong Rocky Mountain High Intensity Drug Trafficking Area 
Marco Vasquez 
Chief, Erie Police Department; Colorado Association of Chiefs of 
Police 
Mark Fleecs Denver Police Department  
Marley Bordovsky Denver City Attorney’s Office 
Nachshon Zohari Denver Drug Strategy 
Rob Madden Colorado State Patrol 
Denver Police Department 
Robert White Chief of Police 
David Quinones Deputy Chief of Police 
Colorado Department of 
Public Health and 
Environment 
Larry Wolk Executive Director and Chief Medical Officer 
Tista Gosh 
Deputy Chief Medical Officer and Director, Disease Control and 
Environmental Epidemiology 
Michael VanDyke University of Colorado Denver, Anschutz Medical Campus 
Ali Maffey Policy and Communication Unit Supervisor 
Karin McGowan Deputy Executive Director and Director, Community Relations 
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Appendix C: Washington State Stakeholders 
Meeting Host Individual Role (Organization if different from meeting host) 
Seattle City Attorney’s Office 
Peter Holmes Executive Director 
John Schochet Deputy Chief of Staff 
Kathleen Harvey  
University of Washington, 
School of Medicine, School 
of Social Work and School of 
Public Health 
(multiple organizations) 
Dr. Dennis Donovan 
Director, Alcohol & Drug Abuse Institute; Professor, Department 
of Psychiatry & Behavioral Sciences 
Roger Roffman Professor Emeritus, School of Social Work 
Beatriz Carlini Senior Research Scientist, Alcohol and Drug Abuse Institute 
Caleb Banta-Green Senior Research Scientist, Alcohol and Drug Abuse Institute 
Sharon Garrett Research Coordinator, Alcohol and Drug Abuse Institute 
Gillian Schauer Research Affiliate, Alcohol and Drug Abuse Institute 
Denise D Walker 
Research Associate Professor, Co-Director, Innovative Programs 
Research Group, School of Social Work 
Christine Lee 
Research Associate Professor, Psychiatry, Associate Director, 
Center for the Study of Health and Risk Behaviors 
Mark Cooke Policy Advocate, American Civil Liberties Union 
Adam Darnell 
Senior Research Associate, Washington State Institute for Public 
Policy 
Jennifer Wyatt 
Training & Program Specialist, Northwest Addiction Technology 
Transfer Center 
Jennifer Velotta 
Clearinghouse Coordinator, Information Services & 
Dissemination, Alcohol and Drug Abuse Institute 
Meg Brunner 
Web Information Specialist, Information Services & 
Dissemination, Alcohol and Drug Abuse Institute 
Kevin Haggerty 
Director, Social Development Research Group, School of Social 
Work 
Nancy Sutherland 
Director, Information Services and Dissemination, Alcohol and 
Drug Abuse Institute 
Katarina Guttmannova Principal Investigator, Social Development Research Group 
Jennifer Bailey Principal Investigator, Social Development Research Group 
King County Sheriff's Office 
Sheriff John Urquhart  
Chris Barringer Chief of Staff 
Seattle Sick Children’s 
Hospital 
Dr. Leslie Walker Chief, Adolescent Medicine 
Inga Manskopf Community Coalition Leader 
Liz Wilhelm Community Coalition Leader 
Kevin Haggerty 
Director, Social Development Research Group, University of 
Washington, School of Social Work 
Cannabis City Dr. James R. Lathrop CEO 
Washington State Economic 
and Revenue Forecast Council 
Lance Carey Senior Economist 
Office of Governor 
Jason McGill Policy Advisor 
Sandy Mullins Policy Advisor 
Xandre Chateaubriand Policy Advisor 
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Washington State 
Department of Social and 
Health Services 
(multiple organizations) 
Jane Beyer 
Assistant Secretary, Behavioral Health and Service Integration 
Administration 
Lisa Hodgson Office Director, Health Professions and Facilities, DOH 
Kristi Weeks Review Officer/Policy Counsel, DOH 
Paul Davis 
Manager, Tobacco Prevention and Control and Marijuana 
Education, DOH 
Rick Garza Director, LCB 
Sarah Mariani Division of Behavioral Health and Recovery 
Mary Segawa Public Health Education Liaison, LCB 
Steven Johnson Deputy Chief, Enforcement, LCB 
Michael Langer Office Chief, Behavioral Health and Prevention, BHSIA 
Harris & Moure, pllc Robert McVay Attorney at Law 
Washington Association for 
Substance Abuse & Violence 
Prevention 
Derek Franklin President 
Northwest High Intensity 
Drug Trafficking Area 
Dr. Steve Freng Prevention/Treatment Manager 
Washington State Patrol Lt. Robert Sharpe Impaired Driving Section Commander 
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Appendix D: Glossary of Terms 
The following terms are commonly used to categorize approaches that fall at various points along the 
regulatory continuum for cannabis. 
Criminalization: The production, distribution and possession of cannabis are subject to criminal 
justice sanctions ranging from fines to incarceration. Conviction results in a criminal record. 
Decriminalization: Non-criminal penalties, for example, civil sanctions such as tickets or fines, 
replace criminal penalties for personal possession. Individuals charged will not, in most cases, 
receive a criminal record. Most decriminalization models retain criminal sanctions for larger-scale 
production and distribution. 
Legalization: Criminal sanctions are removed. The substance is generally still subject to regulation 
that imposes guidelines and restrictions on use, production and distribution, similar to the regulation 
of alcohol and tobacco.  
Regulation: Regulation refers broadly to the legislative or regulatory controls in place with regard to 
the production, distribution and possession of cannabis. The term is, however, increasingly being 
used in reference to the guidelines and restrictions on use, production and distribution of cannabis 
under legalization approaches.  
